These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15211476)

  • 21. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J; Farhood A
    Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
    Zamecnik J; Kodet R
    Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LI-cadherin and CDX2: Useful Markers in Metastatic Gastrointestinal Adenocarcinoma Cells in Serous Cavity Effusion.
    Ma H; Yu J; Tang J
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):e75-e80. PubMed ID: 30095466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDX-2 and HER-3 expression in canine gastric and colorectal adenocarcinomas.
    Doster AR; Yhee JY; Kim JH; Im KS; Sur JH
    J Comp Pathol; 2011 Jul; 145(1):12-9. PubMed ID: 21238975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
    Tornillo L; Moch H; Diener PA; Lugli A; Singer G
    J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of CDX2 immunostaining in diagnosis of gastrointestinal adenocarcinoma].
    Wang C; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):228-31. PubMed ID: 16776981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
    Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
    J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.
    Penman D; Downie I; Roberts F
    J Clin Pathol; 2006 Jun; 59(6):663-4. PubMed ID: 16731609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical detection using CDX2: An aid for discerning tumor involvement in ascites cytology.
    Kobayashi M; Ueyama Y; Nakanishi H; Ishida H; Takahashi E; Nakamura S; Koshikawa T; Yatabe Y
    Cancer; 2006 Apr; 108(2):114-8. PubMed ID: 16541450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors.
    Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C
    Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.
    Malmros K; Lindholm A; Vidarsdottir H; Jirström K; Nodin B; Botling J; Mattsson JSM; Micke P; Planck M; Jönsson M; Staaf J; Brunnström H
    Virchows Arch; 2024 Aug; 485(2):347-357. PubMed ID: 37349623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
    Kim MJ
    J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of thyroid transcription factor-1 in malignant pleural effusions.
    Khoor A; Byrd-Gloster AL; Nicosia SV
    Pathol Oncol Res; 2011 Jun; 17(2):263-7. PubMed ID: 20848248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids.
    Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P
    Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
    Saad RS; Ismiil N; Dubé V; Nofech-Mozes S; Khalifa MA
    Am J Clin Pathol; 2009 Oct; 132(4):531-8. PubMed ID: 19762530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.